To figure out what microbiome therapeutics companies will do next, the best move may be to step away from the press releases and open a scientific journal.
Academic science has been the foundation of almost every treatment, from insulin to gene therapy. But eventually, as a field matures, scientists in industry will start to show up as authors on more and more papers and as presenters at more and more conferences.
About the Author Reprints
